$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017
[Report Updated: 31-03-2017]

Published by Global Data: 31 Mar 2017 | 53440 | In Stock
Related Topics: Clinical Trials

Introduction

Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017" provides an overview of Ancylostomiasis (Hookworm Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Ancylostomiasis (Hookworm Infections). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017 [Report Updated: 31-03-2017]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials by E7 Countries: Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 20

    Clinical Trials in E7 Countries by Trial Status 21

    Clinical Trials by Phase 22

    In Progress Trials by Phase 23

    Clinical Trials by Trial Status 24

    Clinical Trials by End Point Status 25

    Subjects Recruited Over a Period of Time 26

    Clinical Trials by Sponsor Type 27

    Prominent Sponsors 28

    Top Companies Participating in Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials 29

    Prominent Drugs 30

    Latest Clinical Trials News on Ancylostomiasis (Hookworm Infections) 31

    Mar 09, 2017: GW researchers develop test to study potency for neglected tropical disease vaccine 31

    Clinical Trial Profile Snapshots 32

    Appendix 47

    Abbreviations 47

    Definitions 47

    Research Methodology 48

    Secondary Research 48

    About GlobalData 49

    Contact Us 49

    Source 50

List Of Tables
in Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017 [Report Updated: 31-03-2017]

List of Tables

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Region, 2017* 6

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, North America, Top Countries, 2017* 12

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14

Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16

Ancylostomiasis (Hookworm Infections) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17

Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19

Ancylostomiasis (Hookworm Infections) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20

Ancylostomiasis (Hookworm Infections) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Phase, 2017* 22

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26

Ancylostomiasis (Hookworm Infections) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List Of Figures, Charts and Diagrams
in Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017 [Report Updated: 31-03-2017]

List of Figures

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Region (%), 2017* 6

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14

Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15

Ancylostomiasis (Hookworm Infections) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17

Proportion of Ancylostomiasis (Hookworm Infections) to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18

Ancylostomiasis (Hookworm Infections) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20

Ancylostomiasis (Hookworm Infections) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23

Ancylostomiasis (Hookworm Infections) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26

Ancylostomiasis (Hookworm Infections) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29

Ancylostomiasis (Hookworm Infections) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

GlobalData Methodology 48

Additional Details

Publisher

Global Data

Publisher Information

Reference

53440 | GDHC4127CTIDB

Number of Pages

50

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! 2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Hookworm Infections (Ancylostomiasis) Clinical Trials Study”...
24 Apr 2019 by VPA Research USD $1,529 (normally
USD $1,799)
More Info
SAVE 15% today! Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H2, 2018
Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H2, 2018SummaryGlobalData's cli...
31 Oct 2018 by Global Data USD $2,125 (normally
USD $2,500)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Ancylostomiasis (Hookworm Infections) Global Clinical Trials Review, H1, 2017 [Report Updated: 31-03-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...